Sangamo Therapeutics Shares Tumble After Pfizer Cancels Hemophilia Gene Therapy Agreement
Sangamo Therapeutics Faces Instability After Pfizer’s Sudden Exit The financial landscape is often influenced by collaborations and partnerships in the pharmaceutical sector. A recent turn of events has sent Sangamo Therapeutics, Inc. (NASDAQ: SGMO) stock … Read more